Indian bioengineer at Stanford develops a 20-cent, hand-powered blood centrifuge

2017-01-16 07:43:20

Stanford bioengineers Manu Prakash and Saad Bhamla have developed an ultra-low-cost, human-powered blood centrifuge. With rotational speeds of up to 125,000 revolutions per minute, the device separates blood plasma from red cells in 1.5 minutes and no electricity is required.By Team ABLEA news report filed by Kris Newby in Stanford’s website reveals that Stanford bioengineers have developed an i

Read more

ICMR calls for submission of Medical Technologies to exhibit at Innovations in Medical Science and Biotechnology Exhibition in March 2017

2017-01-13 07:34:03

ICMR in collaboration with DBT-BIRAC and NIF-India is organizing a one day exhibition at Rashtrapati Bhavan, New Delhi between March 4 and 10, 2017. Innovators are invited to showcase the developments in medical technologies in poster and physical forms. By Team ABLEICMR in collaboration with DBT-BIRAC and NIF-India is organizing a one day exhibition during Festival of Innovations to be held on th

Read more

USFDA accepts Mylan-Biocon’s application for proposed breast cancer biosimilar

2017-01-12 10:00:37

Biocon and Mylan have jointly announced that the USFDA has accepted Mylan’s biologics license application (BLA) for MYL-1401O, a proposed biosimilar trastuzumab, for filing through the 351(k) pathway. By Team ABLEIndia’s most successful biopharmaceutical company Biocon and NASDAQ-listed Mylan NV have jointly announced that the US Food and Drug Administration (USFDA) has accepted Mylan’s biol

Read more

DBT calls for Energy Biosciences Overseas Fellowships and DBT Energy Biosciences Chairs positions

2017-01-12 09:59:22

This is a re-entry scheme aimed at bringing back young scientists of Indian origin working overseas to pursue R&D in energy related biosciences in an Indian institutionBy Team ABLEUnder the aegis of Department of Biotechnology, Ministry of Science and Technology, Government of India the Energy Biosciences Research is spearheading to develop bio-based renewable fuels for the country.With this a

Read more

Intas Pharmaceuticals completes deal to acquire Actavis UK, Ireland generics businesses from Teva

2017-01-12 09:56:52

Intas Pharmaceuticals, through its wholly-owned subsidiary Accord Healthcare, has completed the deal to acquire Actavis UK & Actavis Ireland from Teva Pharmaceutical IndustriesBy Team ABLEIntas Pharmaceuticals, through its wholly-owned subsidiary Accord Healthcare, has completed the deal to acquire Actavis UK & Actavis Ireland (Actavis UK & Ireland) from Teva Pharmaceutical Industries,

Read more

PM inaugurates Nobel Prize Series at Vibrant Gujarat Summit; Nobel laureates opine that India has a great potential to be a scientific powerhouse

2017-01-11 09:13:00

At the Nobel Prize Series held as part of the Vibrant Gujarat Global Summit 2017, several Nobel laureates opined that India has a great potential to be a scientific power and consider investing more in basic & fundamental researches. Dr. Venkatraman Ramkrishnan pointed out that there is a lot of scope for research on vaccines in India.By Team ABLEPrime Minister Narendra Modi inaugurated the No

Read more

Johnson & Johnson Innovation, New York State, New York Genome Center collaborate to launch JLABS in New York City

2017-01-11 09:10:19

Called JLABS @ NYC, the 30,000-square foot facility will be located at the New York Genome Center (NYGC) in SoHo and will open in 2018.By Team ABLEJohnson & Johnson Innovation LLC, New York State and the New York Genome Center have announced a collaboration to launch a new JLABS in New York City. Called JLABS @ NYC, the 30,000-square foot facility will be located at the New York Genome Center

Read more

Evolva expects to launch EverSweet stevia in 2018

2017-01-10 11:13:23

Evolva  has updated its shareholders on its collaboration with Cargill on the next-generation stevia sweetener, EverSweet, and its preliminary, unaudited, 2016 top-line financials.By Team ABLEProviding an update on it Stevia collaboration with Cargil,  Evolva  informed its stakeholders that Evolva and Cargill made solid progress on EverSweet during 2016. The FDA issued a GRAS No Obj

Read more

Takeda to boost global oncology portfolio with ARIAD Pharmaceuticals’ acquisition for $5.2 billion

2017-01-10 11:10:54

Takeda has firmed plans to acquire all of the outstanding shares in ARIAD for $24.00 per share in cash, or an enterprise value of approximately $5.2 billion to strengthen its oncology portfolio of therapeutics.  By Team ABLEJapanese pharmaceutical giant Takeda Pharmaceutical Company and NASDAQ-listed ARIAD Pharmaceuticals have entered into a definitive agreement under which Takeda will acquir

Read more

Global biotechnology market size to reach $604.40 billion by 2020: Grand View Research report

2017-01-10 11:09:09

The report indicates that increasing demand for biotechnology based diagnostics and therapeutics solutions such as recombinant technology, red biotechnology and DNA sequencing is expected to drive market growth.By Team ABLEA new research report by Grand View Research estimates that the global biotechnology market size is expected to reach USD 604.40 billion by 2020. The report indicates that incre

Read more